PRECIGEN Investors

Events & Presentations

Events & Presentations

Upcoming Events

Past Events

Dec 07, 2020 at 7:00 AM - 3:30 PM PST
Precigen presented abstract entitled "A Phase 1/1b Safety Study of PRGN-3006 UltraCAR-T in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndrome." (Abstract 2864)
Read More
Jun 22, 2020

Tim Chan, PhD, Senior Director, Immuno-Oncology of Precigen presented the poster “PRGN-3005 UltraCAR-T™: Multigenic CAR-T Cells Generated Using Non-viral Gene Delivery and Rapid Manufacturing Process for the Treatment of Ovarian Cancer”. (Abstract 6593)

Read More
Dec 08, 2019 at 6:00 PM EST

Tim Chan, PhD, Senior Director, Immuno-Oncology of Precigen presented the poster “Preclinical Characterization of PRGN-3006 UltraCAR-T™ for the Treatment of AML and MDS: Non-Viral, Multigenic Autologous CAR-T Cells Administered One Day after Gene Transfer.” (Abstract #2660)

Orlando, FL
Read More